Business
Abattis Bioceuticals to be featured on CEO clips airing on BNN
Abattis Bioceuticals to be featured on CEO clips airing on BNN.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n\nv\\:* {behavior:url(#default#VML);}\no\\:* {behavior:url(#default#VML);}\nw\\:* {behavior:url(#default#VML);}\n.shape {behavior:url(#default#VML);}\n\n\n\nAbattis Bioceuticals to\nBe Featured on CEO Clips Airing on BNN\n\n \n\nVancouver, BC ? June 27, 2014 ? Abattis Bioceuticals Corp.\n(the ?Company? or ?Abattis?) (OTC Pink: ATTBF) (CSE: ATT), a specialty\nbiotechnology company focused on cultivating, licensing, and marketing\nproprietary ingredients, bio-similar compounds, equipment, and consulting\nservices to North American medicinal markets, today announced that CEO Clips\nwill be running a series of commercials on Canada?s Business News Network\n(?BNN?) advertising the Company?s upcoming BTV Business Television segment are\nto be shown on July 19th and July 20th.\n\nCEO Clips, a news/media organization profiling some of the\nmost innovative publicly traded companies in North America, will feature a 15\nto 30 second commercial advertising the Company?s upcoming BTV Business\nTelevision segment to be aired on July 19th and July 20th.\nThe segment features Mike Withrow, President of Abattis discussing the industry,\ncompany, and upcoming catalysts from its Phytalab location in Seattle. The\ncommercials are currently airing from June 25th through June 29th,\nJuly 14th through July 20th, and August 18th\nthrough August 24th on BNN.\n\nThe CEO Clips commercial can also be viewed online at: http://www.ceoclips.com/SingleCommercial.aspx?clipid=272\n\nBNN reaches Canada?s most targeted audience of 1.7 million\nweekly and 6.3 million total retail and financial investors. With its focus on\nthe financial industry, the broadcasts attract predominantly investors in\nstocks, bonds, and luxury goods over the age of 35 with average incomes of over\n$100,000 per year.\n\n?BNN is Canada?s premier business and financial news station\nreaching millions of households each week,? said Abattis Bioceuticals Corp. CEO\nMike Withrow. ?We are excited to raise our profile among the Canadian\ninvestment community as we continue to execute on our business plan and build\nlong-term value.?\n\nAbout Abattis Bioceuticals Corp.\n\nAbattis is a specialty biotechnology company with\ncapabilities through its wholly owned subsidiaries of cultivating, licensing\nand marketing proprietary ingredients, bio-similar compounds, patented\nequipment and consul...